User contributions
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 16:35, 12 September 2014 (diff | hist) . . (+147) . . Economic evaluation (Caveat if vaccine is cost saving)
- 15:56, 12 September 2014 (diff | hist) . . (+582) . . Tendering process for pneumococcal conjugate vaccine (Answer: vaccine price should be the predominant selection criterion)
- 13:45, 12 September 2014 (diff | hist) . . (-5) . . m Economic evaluation
- 13:43, 12 September 2014 (diff | hist) . . (+307) . . Economic evaluation (sensitivity statement)
- 08:00, 11 September 2014 (diff | hist) . . (+414) . . Cost effectiveness sensitivity (uncertainty conclusion added)
- 12:56, 2 September 2014 (diff | hist) . . (+7,883) . . N Talk:Comparison criteria (comments copied from the Finnish page)
- 11:15, 27 August 2014 (diff | hist) . . (+224) . . Economic evaluation
- 10:24, 27 August 2014 (diff | hist) . . (+20) . . Epidemiological modelling
- 10:20, 27 August 2014 (diff | hist) . . (-2) . . Epidemiological modelling
- 10:19, 27 August 2014 (diff | hist) . . (+1) . . Epidemiological modelling (computation now in "answer" section)
- 14:13, 25 August 2014 (diff | hist) . . (+27) . . Economic evaluation (incl. sequlae lisätty)
- 11:52, 25 August 2014 (diff | hist) . . (+113) . . Economic evaluation
- 10:21, 25 August 2014 (diff | hist) . . (0) . . Epidemiological modelling
- 10:20, 25 August 2014 (diff | hist) . . (+18) . . Epidemiological modelling
- 10:12, 25 August 2014 (diff | hist) . . (+1,302) . . Epidemiological modelling (data table added)
- 09:41, 25 August 2014 (diff | hist) . . (+26) . . Epidemiological modelling
- 21:16, 24 August 2014 (diff | hist) . . (-3) . . Economic evaluation (Table updated)
- 20:54, 24 August 2014 (diff | hist) . . (+121) . . Economic evaluation
- 19:12, 24 August 2014 (diff | hist) . . (+249) . . m Cost effectiveness sensitivity
- 19:00, 24 August 2014 (diff | hist) . . (+2) . . m Economic evaluation
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)